Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.
Momeny M, Yousefi H, Eyvani H, Moghaddaskho F, Salehi A, Esmaeili F, Alishahi Z, Barghi F, Vaezijoze S, Shamsaiegahkani S, Zarrinrad G, Sankanian G, Sabourinejad Z, Hamzehlou S, Bashash D, Aboutorabi ES, Ghaffari P, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: esmaeili f. Int J Biochem Cell Biol. 2018 Jun;99:1-9. doi: 10.1016/j.biocel.2018.03.015. Epub 2018 Mar 19. Int J Biochem Cell Biol. 2018. PMID: 29567488
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
Momeny M, Zarrinrad G, Moghaddaskho F, Poursheikhani A, Sankanian G, Zaghal A, Mirshahvaladi S, Esmaeili F, Eyvani H, Barghi F, Sabourinejad Z, Alishahi Z, Yousefi H, Ghasemi R, Dardaei L, Bashash D, Chahardouli B, Dehpour AR, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: esmaeili f. Sci Rep. 2017 Jun 23;7(1):4204. doi: 10.1038/s41598-017-04147-0. Sci Rep. 2017. PMID: 28646172 Free PMC article.
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.
Yousefi H, Momeny M, Ghaffari SH, Parsanejad N, Poursheikhani A, Javadikooshesh S, Zarrinrad G, Esmaeili F, Alishahi Z, Sabourinejad Z, Sankanian G, Shamsaiegahkani S, Bashash D, Shahsavani N, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A. Yousefi H, et al. Among authors: esmaeili f. Tumori. 2019 Feb;105(1):84-91. doi: 10.1177/0300891618784790. Epub 2018 Jul 19. Tumori. 2019. PMID: 30021477
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.
Momeny M, Esmaeili F, Hamzehlou S, Yousefi H, Javadikooshesh S, Vahdatirad V, Alishahi Z, Mousavipak SH, Bashash D, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Haddad P, Kordbacheh F, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Momeny M, et al. Among authors: esmaeili f. Cell Oncol (Dordr). 2019 Aug;42(4):491-504. doi: 10.1007/s13402-019-00448-w. Epub 2019 Apr 25. Cell Oncol (Dordr). 2019. PMID: 31025257
Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells.
Momeny M, Sankanian G, Hamzehlou S, Yousefi H, Esmaeili F, Alishahi Z, Karimi B, Zandi Z, Shamsaiegahkani S, Sabourinejad Z, Kashani B, Nasrollahzadeh A, Mousavipak SH, Mousavi SA, Ghaffari SH. Momeny M, et al. Among authors: esmaeili f. Eur J Pharmacol. 2020 Sep 5;882:173298. doi: 10.1016/j.ejphar.2020.173298. Epub 2020 Jun 25. Eur J Pharmacol. 2020. PMID: 32593665
Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.
Momeny M, Eyvani H, Barghi F, Ghaffari SH, Javadikooshesh S, Hassanvand Jamadi R, Esmaeili F, Alishahi Z, Zaghal A, Bashash D, Samani FS, Ghaffari P, Dehpour AR, Tavangar SM, Alimoghaddam K, Ghavamzadeh A. Momeny M, et al. Among authors: esmaeili f. Anticancer Drugs. 2018 Nov;29(10):1011-1020. doi: 10.1097/CAD.0000000000000681. Anticancer Drugs. 2018. PMID: 30096128
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.
Zandi Z, Kashani B, Alishahi Z, Pourbagheri-Sigaroodi A, Esmaeili F, Ghaffari SH, Bashash D, Momeny M. Zandi Z, et al. Among authors: esmaeili f. J Cancer Res Clin Oncol. 2022 Jan;148(1):57-70. doi: 10.1007/s00432-021-03874-2. Epub 2022 Jan 4. J Cancer Res Clin Oncol. 2022. PMID: 34981193 Review.
112 results